Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Business https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Johnson & Johnson single shot vaccine in trial: Report

Johnson & Johnson single shot vaccine in trial: Report



Johnson & Johnson’s (JNJ) – Get report The single-shot vaccine candidate has been shown to be safe and generate a meaningful immune response in an early-stage trial, according to a published report Wednesday.




Source link